179 related articles for article (PubMed ID: 33438994)
1. Liquid CO
Raza A; Sime FB; Cabot PJ; Roberts JA; Falconer JR; Kumeria T; Popat A
ACS Biomater Sci Eng; 2021 May; 7(5):1836-1853. PubMed ID: 33438994
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery.
Raza A; Alavi SE; Sime FB; Han FY; Roberts JA; Popat A; Falconer JR; Kumeria T
Acta Biomater; 2021 May; 126():277-290. PubMed ID: 33774198
[TBL] [Abstract][Full Text] [Related]
3. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
4. A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.
Kassem AM; Almukainzi M; Faris TM; Ibrahim AH; Anwar W; Elbahwy IA; El-Gamal FR; Zidan MF; Akl MA; Abd-ElGawad AM; Elshamy AI; Elmowafy M
Eur J Pharm Sci; 2024 Jan; 192():106652. PubMed ID: 38008226
[TBL] [Abstract][Full Text] [Related]
5. PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery.
Raza A; Miles JA; Sime FB; Ross BP; Roberts JA; Popat A; Kumeria T; Falconer JR
Int J Pharm; 2021 Mar; 597():120280. PubMed ID: 33540004
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon.
Nguyen CT; Webb RI; Lambert LK; Strounina E; Lee EC; Parat MO; McGuckin MA; Popat A; Cabot PJ; Ross BP
ACS Appl Mater Interfaces; 2017 Mar; 9(11):9470-9483. PubMed ID: 28252278
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant
Memar MY; Yekani M; Ghanbari H; Shahi S; Sharifi S; Maleki Dizaj S
Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1354-1361. PubMed ID: 33236938
[TBL] [Abstract][Full Text] [Related]
8. Gastro-protective protein-silica nanoparticles formulation for oral drug delivery: In vitro release, cytotoxicity and mitochondrial activity.
Juère E; Del Favero G; Masse F; Marko D; Popat A; Florek J; Caillard R; Kleitz F
Eur J Pharm Biopharm; 2020 Jun; 151():171-180. PubMed ID: 32302657
[TBL] [Abstract][Full Text] [Related]
9. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers.
Gao Y; He Y; Zhang H; Zhang Y; Gao T; Wang JH; Wang S
J Colloid Interface Sci; 2021 Jan; 582(Pt A):364-375. PubMed ID: 32861041
[TBL] [Abstract][Full Text] [Related]
10. Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin.
Ndayishimiye J; Cao Y; Kumeria T; Blaskovich MAT; Falconer JR; Popat A
J Mater Chem B; 2021 Sep; 9(35):7145-7166. PubMed ID: 34525166
[TBL] [Abstract][Full Text] [Related]
11. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
Li Z; Zhang Y; Zhang K; Wu Z; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Evaluation of pH Responsive Doxazosin Loaded Mesoporous Silica Nanoparticles: A Smart Approach in Drug Delivery.
Guha A; Biswas N; Bhattacharjee K; Das P; Kuotsu K
Curr Drug Deliv; 2016; 13(4):574-81. PubMed ID: 26201344
[TBL] [Abstract][Full Text] [Related]
13. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
[TBL] [Abstract][Full Text] [Related]
14. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
15. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
[TBL] [Abstract][Full Text] [Related]
16. Construction of selenium-embedded mesoporous silica with improved antibacterial activity.
Chen J; Wei Y; Yang X; Ni S; Hong F; Ni S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110910. PubMed ID: 32126358
[TBL] [Abstract][Full Text] [Related]
17. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
